Cytokinetic evaluation of the four-drug combination of bleomycin, vincristine, mitomycin c, and methotrexate (BOMM) in cultured burkitt'S lymphoma cells and human bone marrow

MLA

Timothy O’Toole, et al. “Cytokinetic Evaluation of the Four-Drug Combination of Bleomycin, Vincristine, Mitomycin c, and Methotrexate (BOMM) in Cultured Burkitt’S Lymphoma Cells and Human Bone Marrow.” Cancer, vol. 50, Nov. 1982, pp. 1993–99. EBSCOhost, https://doi.org/10.1002/1097-0142(19821115)50:10<1993::aid-cncr2820501003>3.0.co;2-q.

APA

Timothy O’Toole, Daniel J. Clauw, Richard H. Wheeler, & William D. Ensminger. (1982). Cytokinetic evaluation of the four-drug combination of bleomycin, vincristine, mitomycin c, and methotrexate (BOMM) in cultured burkitt’S lymphoma cells and human bone marrow. Cancer, 50, 1993–1999. https://doi.org/10.1002/1097-0142(19821115)50:10<1993::aid-cncr2820501003>3.0.co;2-q

Chicago

Timothy O’Toole, Daniel J. Clauw, Richard H. Wheeler, and William D. Ensminger. 1982. “Cytokinetic Evaluation of the Four-Drug Combination of Bleomycin, Vincristine, Mitomycin c, and Methotrexate (BOMM) in Cultured Burkitt’S Lymphoma Cells and Human Bone Marrow.” Cancer 50 (November): 1993–99. doi:10.1002/1097-0142(19821115)50:10<1993::aid-cncr2820501003>3.0.co;2-q.